• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Cellectis Snags $164 Million in IPO to Advance CAR-T Programs biospace
    April 12, 2018
    During the J.P. Morgan Healthcare Conference Andre Choulika, chief executive officer of France-based Cellectis told BioSpace he was excited about the future of CAR-T therapiesand where his company fits into the space.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service